Skip to main content
OpenTrials
Completed

NCT Number: NCT00825864

Diclofenac vs Dexamethasone in Combined Surgery

To study the effect of Diclofenac drops or Dexamethasone drops on combined surgery of trabeculectomy and cataract surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Cataract Eye Diseases Lens Diseases Ocular Hypertension

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Goldschleger Eye Institute, Sheba Medcial Center

Tel Litwinsky, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients scheduled for combines surgery of trabeculectomy and cataract surgery

Exclusion criteria

  • severe complicated surgery like vitreal loss, expulsive hemorrhage, endophthalmitis

Treatment and study plan

diclofenac drops

Drug

one drop 4 times a day for 3 months

dexamethasone sodium phosphate 0.1% eye drops

Drug

for first week after the operation : one drop 6 times a day. Then tapering by reducing one drop for a week

Primary outcomes

  1. intraocular pressure

    Time frame: year

Secondary outcomes

  1. the number of antiglaucoma medications

    Time frame: year

Sponsors and collaborators

Lead sponsor

Sheba Medical Center

Other Gov

Registry information

Official study title

Evaluation the Effect of Diclofenac Drops vs Dexamethasone Drops in Trabeculectomy and Cataract Surgery

Important dates

Study start
2004
Primary completion
2008
Study completion
2008
First posted
Jan 21, 2009
Registry last updated
Jan 21, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.